tradingkey.logo
tradingkey.logo
검색

MPT 2026년 3분기 실적 발표 컨퍼런스 콜: FFO 0.11달러, 부채 리파이낸싱 및 임대료 업데이트

TradingKeyOct 29, 2026 8:11 PM
facebooktwitterlinkedin
모든 코멘트 보기(0)

메디컬 프로퍼티스 트러스트(MPT)는 2026년 3분기 주당 0.11달러의 조정 FFO를 발표했다. HSA의 9월 임대료 미납 영향이 있었으나 경영진 예상치에 부합했다. 연초 이후 현금 매출은 7억 5,000만 달러를 초과했다. 8월에 24억 달러 규모의 부채 리파이낸싱을 완료해 순할인 차익을 확보했다. 프라이어리와의 계약을 통해 연간 임대료 의무를 약 18% 감축했으며, 임대 연장 옵션을 포함했다. HSA의 임대료 지급 시점은 불확실하며, 오베이션 헬스케어가 병원 경영 책임을 맡았다. 경영진은 2단계 리파이낸싱을 통해 2028년 6월까지 만기 부채가 없을 것으로 기대하고 있다.

AI 생성 요약

핵심 요약

  • 메디컬 프로퍼티스 트러스트(MPT)는 HSA의 9월 미납 임대료를 제외하고 경영진의 예상치에 부합하는 주당 0.11달러의 2026년 3분기 조정 FFO를 발표했습니다.
  • 연초 이후 누적 현금 매출은 7억 5,000만 달러를 초과해 연환산 기준 10억 달러를 상회했습니다. 경영진은 자산 매각에도 불구하고 포트폴리오 현금 임대료가 10억 달러를 넘어설 것이라는 전망을 유지하고 있습니다.
  • MPT는 8월에 24억 달러 규모의 담보부 부채 리파이낸싱을 완료하여 약 1억 2,300만 달러의 순할인 차익을 확보했습니다. 이 중 7,000만 달러는 분기 이익으로 인식했습니다.
  • MPT와 프라이어리(Priory)는 연간 임대료 의무를 초기 기준으로 약 18%(약 1,100만 파운드) 감축했습니다. 수정된 계약에는 가변 임대료 회수 조항과 MPT가 제어하는 2055년까지의 임대 연장 옵션이 포함되어 있습니다.
  • HSA의 임대료 지급 시점은 여전히 불확실합니다. 경영진은 8월 이후 현금 회수액이 24% 증가한 반면, 오베이션 헬스케어(Ovation Healthcare)가 병원 포트폴리오 전반의 경영 책임을 맡았다고 밝혔습니다.
  • MPT는 리파이낸싱 계획의 2단계를 진행 중이며, 경영진은 이를 통해 남은 2027년 만기 채무를 해결하고 2028년 6월까지 부채 만기가 도래하지 않을 것으로 기대하고 있습니다.

주요 재무 데이터

지표2026년 3분기 / 최근 현황비고
조정 FFO주당 $0.11HSA의 9월 미납 임대료 영향 포함
연초 이후 누적 현금 매출7억 5,000만 달러 초과연환산 시 10억 달러 초과
8월 담보부 사채 발행24억 달러부채 상환 및 교환에 사용
순 부채 교환 할인액약 1억 2,300만 달러7,000만 달러는 3분기 이익으로 인식, 잔액은 사채 만기까지 이자비용을 통해 인식 예정
분기 자산 현금화 이익1억 5,800만 달러해당 분기 중 완료된 거래에서 계상
프라이어리 연간 임대료 감축액약 1,100만 파운드약 18% 감축에 해당하며, 향후 가변 임대료 회수 가능성 포함
손상차손약 2,400만 달러8월 지진 발생 이후 콜롬비아 투자 관련 손상이 주를 이룸
HSA 대출 잔액약 1억 5,000만 달러애널리스트 Q&A에서 공개
비담보 자산 대비 무담보 부채 비율180% 초과채권 약정 기준인 150%를 상회하며, 경영진은 리파이낸싱 2단계 완료 후 최대 225%까지 상승할 것으로 예상

사업 및 운영 실적

MPT는 급성기 후 치료(Post-acute care) 부문이 포트폴리오 모멘텀의 주요 원천으로 유지된 반면, 일반 급성기 치료 실적은 대체로 안정적이었다고 밝혔습니다. 정신건강 운영사들은 인력 구성, 서비스 믹스 및 환자 의뢰 연계 개선 노력을 지속했습니다.

유럽에서는 메디안(Median)이 정형외과, 정신신체 치료 및 중독 치료 부문을 중심으로 높은 병상 가동률을 기록했으며 비용 관리도 개선되었습니다. 서클 헬스(Circle Health)는 매출 증가, 안정적인 진료량, 견조한 마진을 기록했습니다.

스위스 메디컬 네트워크(Swiss Medical Network)는 7월 인프라코어(Infracore) IPO 이후 전년 대비 병원 매출 성장과 2배 이상의 임대료 보상배율을 보고했습니다. 스페인의 IMED는 발렌시아 시설의 약 40% 성장에 힘입어 수술 건수가 전년 대비 11% 이상 증가했습니다. 알리칸테와 바르셀로나의 신규 병원은 수용 능력을 확대할 것으로 예상됩니다.

미국에서는 어니스트 헬스(Ernest Health)가 2.5배의 임대료 보상배율을 유지했습니다. NOR은 전년 대비 진료량 증가와 전체 계약 임대료 기준 2.4배의 보상배율을 기록했습니다. NOR은 연체 없이 계약 임대료의 50%를 지급하고 있었으며 12월에 100% 지급으로 복귀할 예정이었습니다.

HSA는 주요 운영 관심사로 남아 있습니다. 경영진은 9월 이후 전체 진료량이 14% 증가하고 수술 건수는 33% 늘어났다고 밝혔습니다. 현금 회수액은 8월 대비 24% 증가했지만, 경영진은 임대료 지급 재개 일자를 제시하지 않았습니다. 미국 내 500개 이상의 병원을 관리하는 오베이션 헬스케어(Ovation Healthcare)가 수익 주기 관리, IT, 인력 관리, 공급망 및 기타 운영 기능을 전담하게 되었습니다.

경영진 전망

경영진은 연중 9개 자산을 매각하여 약 6억 달러의 현금을 확보했음에도 불구하고 연간 포트폴리오 현금 임대료가 10억 달러를 상회할 것이라는 전망을 유지하고 있습니다.

회사는 향후 몇 주 내에 새로운 다년제 회전대출 한도(Revolving credit facility) 계약을 완료할 것으로 예상하고 있습니다. 경영진은 이번 대출 한도 신설을 통해 담보부 레버리지 약정이 제거되고 고정비 보상배율 및 총레버리지 약정의 여유 한도가 추가로 확보될 것이라고 설명했습니다.

MPT 리파이낸싱 계획의 2단계는 회전대출 연장, 2027년 6월 만기인 2억 달러 규모의 기간대출 영구 상환, 2027년 만기 사채 잔액 6억 6,500만 달러의 리파이낸싱을 목표로 합니다. 구상대로 완료될 경우 경영진은 약 6억 달러 규모의 파운드화 채권 만기가 도래하는 2028년 6월까지 MPT의 만기 부채가 없을 것으로 기대합니다.

위험 요소 및 주요 관전 포인트

HSA는 9월 임대료를 지급하지 않았으며, 경영진은 회수가 언제 재개될지 특정하지 못했습니다. 병원 진료량과 현금 회수액은 개선되었으나, MPT는 청구 및 회수를 핵심 운영 문제로 지목했습니다.

프라이어리는 영국 국민보건서비스(NHS)의 예산 제약으로 인한 압박을 계속 받고 있으며, 이로 인해 정신건강 시설 내 NHS 지원 환자 수가 제한되었습니다. MPT의 임대료 감축은 단기적인 부담을 완화해 주는 반면, 회복 여부는 프라이어리가 특정 매출 기준치에 도달하느냐에 달려 있습니다.

MPT의 2단계 리파이낸싱은 아직 완료되지 않았습니다. 시기와 구조는 여전히 검토 중이나, 경영진은 조속히 완료하기를 선호한다고 언급했습니다.

MPT는 지난 8월 발생한 지진 이후 콜롬비아 투자 자산과 관련해 주로 약 2,400만 달러의 손상차손을 계상했습니다.

애널리스트 Q&A 주요 내용

HSA에 대해 경영진은 병원 활동 호조가 아직 명확한 임대료 지급 재개 일자로 이어지지 않았다고 밝혔습니다. 병원 운영 실적이 악화되거나 지속적으로 저하될 경우 보다 대대적인 운영사 교체를 검토할 것이라고 덧붙였습니다.

프라이어리에 대해 경영진은 프라이어리 및 그 모회사를 포함한 신용 범위(Credit perimeter) 개선을 강조했습니다. 또한 MPT는 2055년까지 임대를 연장할 수 있는 독점적 재량권을 확보했으며, 매출이 개선되면 감축된 임대료의 일부 또는 전부를 회수할 수 있습니다.

부채 감축과 관련해 경영진은 2단계 자금 조달로 남은 2027년 만기 채무를 해결할 수 있을 것으로 예상했습니다. 이후 자산 매각 대금은 만기가 긴 부채 상환에 쓰일 수 있으나 구체적인 배분 방식은 결정되지 않았습니다.

경영진은 보류 중인 유의미한 자산 매각 건은 없으며 MPT가 특정 포트폴리오를 적극적으로 매각 추진 중이지 않다고 밝혔습니다. 그러나 회사가 만기 연장과 부채 감축을 지속함에 따라 일회성 거래는 여전히 가능합니다.

실적 발표 컨퍼런스 콜 전문


전체 실적 발표 컨퍼런스 콜 녹취록

경영진 발표

Operator

Hello, everyone. Welcome to the Medical Properties Third Quarter 2026 Earnings Conference Call. [Operator Instructions] After todays' prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press star one to raise your hand. [Operator Instructions] I will now hand the conference call over to Charles Lambert, Senior Vice President. Charles, please go ahead.

Charles Lambert

Good morning. Welcome to the MPT conference call to discuss our third quarter 2026 financial results. With me today are Edward K Aldag Jr., Chairman, President and Chief Executive Officer of the company. Steven Hamner, Executive Vice President and Chief Financial Officer; Kevin Hanna, Senior Vice President, Controller and Chief Accounting Officer; Rose Williams, Senior Vice President of Operations and Secretary; and Jason Fray, Managing Director, Asset Management and underwriting.

Our press release was distributed this morning and furnished on Form 8-K with the Securities and Exchange Commission. If you did not receive a copy, it is available on our website at mpt.com in the Investor Relations section. Additionally, we're hosting a live webcast of today's call, which you can access in that same section.

During the course of this call, we will make projections and certain other statements that may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our financial results and future events to differ materially from those expressed and/or underlying such forward-looking statements.

We refer you to the company's reports filed with the Securities and Exchange Commission for a discussion of the factors that could cause the company's actual results or future events to differ materially from those expressed in this call. The information being provided today is as of this date only, and except as required by the federal securities laws, the company does not undertake a duty to update any such information.

In addition, during the course of the conference call, we will describe certain non-GAAP financial measures, which should be considered in addition to and not in lieu of comparable GAAP financial measures. Please note that in our press release, MPT has reconciled all non-GAAP financial measures to the most directly comparable GAAP measures in accordance with Reg G requirements. You can also refer to our website at mpt.com for the most directly comparable financial measures and related reconciliations. I will now turn the call over to our Chief Executive Officer, Ed Aldag.

Edward Aldag

Thank you, Charles, and thank all of you for joining us this morning. Earlier this year, we projected MPT would reach annualized cash rental revenue of at least $1 billion by the end of this year. Year-to-date, we have already collected more than $750 million of cash revenue, which annualizes to more than the $1 billion we projected earlier. .

This reflects the strength of our diverse portfolio of operators around the world. During the year, we've sold 9 properties for cash proceeds of approximately $600 million, and we still hit our target for 2027. Despite these cells, we continue to expect portfolio cash rent above $1 billion.

Now I'd like to address some recent changes at HSA. Many of you are aware that the 2 principles leading HSA have been engaged in a legal dispute that has served as an unfortunate distraction from core hospital operations. With the resolution of this matter and the exit of one of those principles, we now have a new tenant in place that goes by the name of our [indiscernible].

At this time, the hospitals will continue to operate under the HSA game. As we have discussed in the past few quarters, HSA's core challenges remain revenue cycle management. Simply put, these hospitals have not done a good enough job of billing and collecting.

To address these continued challenges, HSA has engaged Ovation Healthcare based in Nashville, Tennessee, to provide management services Ovation manages over 500 hospitals across the U.S. and will immediately take over all aspects of operations across the portfolio, including revenue cycle, IT staffing, supply chain and other areas.

Ovation's immediate focus will be on improving RCM. We are optimistic that Ovation can help HSA to unlock the significant potential of these hospitals. Turning to the U.K., where we have been discussing budget constraints that have adversely impacted the NHS for several quarters now. As a result of these challenges, the NHS has not been able to fully fund the robust demand the country continues to see for vehicle health services.

Recognizing these ongoing dynamics, MPT and Priory have reached an agreement to reduce the annual rental obligations by approximately 18% with the ability for rents to increase as patient volumes recover. As part of this agreement, we added an extension option at MPT's election that effectively extends priority lease by 10 years.

Following our recent asset sales at attractive valuations and the comprehensive steps we have taken to refinance our debt, as Steve will discuss in more detail shortly, we have meaningfully strengthened our balance sheet this year. Additionally, as ROSA will cover, our portfolio consists of more than 50 operators around the world that are well positioned to continue servicing increased global demand for health care services.

As such, we remain confident that our business model is as important today as it has ever been, and we are well positioned to achieve our financial objectives and to create enduring value for our shareholders. Rosa?

Rosa Hooper

Thank you, Ed. Across the portfolio, Coast acute care remains a notable source of momentum general acute performance is broadly stable and operators in behavioral health are taking targeted steps to improve staffing, service mix and referral alignment.

Across Europe, operators are benefiting from strong performance trends. Median delivered another quarter of solid performance, driven by strong occupancy, particularly in orthopedics and psychosomatic and addiction treatment, combined with proved cost management. Circle help continues its strong performance, delivering increased revenue, consistent volumes and robust margins.

Following the successful Infracore IPO in July, Swiss Medical Network reported increasing hospital revenue year-over-year and coverage surpassing 2x, driven by its growing integrated care networks and cost containment initiatives.

Finally, in Spain, AMED is generating notable volume growth with surgeries increasing more than 11% year-over-year led by a nearly 40% increase at IMED alone in Valencia, which is reaching stabilization in its third year of operations. The opening of the new hospitals in Alicante and Barcelona in the coming months will further expand IMD's capacity in attractive Spanish markets.

In the U.S. Ernest Health remains a standout post-acute operator, maintaining a consistent coverage of 2.5x. NOR continues to produce strong earnings with volumes up year-over-year and coverage of 2.4x on full contractual rent. Nor is currently paying 50% of contractual rent as scheduled and with all payments current, and we'll begin paying 100% contractual rent in December.

In summary, we see meaningful momentum across several of our largest investments along with practical operating plans where improvement is needed. The strength of our portfolio's diversity is as evident as it has ever been. Post-acute care remains a clear portfolio differentiator supported by improving coverage and favorable demand. We are also encouraged by early signs of stabilization in behavioral health, while our general acute portfolio generates solid coverage. Together, these trends demonstrate the value of our diversified portfolio. Kevin?

James Hanna

Thank you, Rosa. Today, we reported normalized FFO of $0.11 per share for the third quarter of 2026. The which was in line with our expectations, excel for the nonpayment of September rent from HSA. The $2.4 billion secured debt refinancing transaction that was completed in August included extinguishments of existing unsecured notes at par and other extinguishments of debt below par, capturing an approximate $123 million of net discount.

We recognized $70 million of this discount as a gain in the quarter with the remainder to be recognized through interest expense over the term of the notes. Also in the quarter, we agreed to a rent modification of approximately 11 million pounds annually to Priority. We have incorporated a variable rent component to recapture some or all of that rent and priority were to reach certain revenue hurdles.

We've also effectively extended the lease term by an additional 10 years. The lease will continue to be classified as an operating lease and no material changes expected from a GAAP revenue perspective. As Ed mentioned, we monetized certain assets during the quarter. an aggregate, we recorded $158 million of gains on those transactions.

G&A expense for the quarter was lower year-over-year, primarily driven by stock compensation expense due to the change in fair market value of certain cash settled stock awards. Finally, during the quarter, we incurred approximately $24 million in impairment charges primarily related to our investments in Colombia due to the major earthquake the country suffered in August, with that said, our team has had recent discussions with representatives of the Colombian government, and we are encouraged about the direction and future of our facilities there. Steve?

R. Hamner

Thank you, Kevin. Last quarter, we described a 2-step process for addressing our 2026 and 2027 maturities and reducing our debt. I'll give a brief recap of Step 1, which was completed in early August, and a status report on step 2. In August, we issued $2.4 billion of secured notes to first fully redeem the EUR 500 million of notes due earlier this month, second, redeem about $735 million of the $1.4 billion of notes due next October. And third, exchange about $1 billion of longer-dated notes.

Through this exchange, we captured about $123 million in net discount and Kevin has just described the accounting for that. Step 2 will involve, one, the extension of our multiyear bank revolver two, the permanent repayment of our $200 million term loan due in June 2027 and three, the refinancing of the remaining $665 million in the 2027 notes.

Although Step 2 is not yet completed, I will describe our current progress as of today. We are in the bank market for a new multiyear revolver that we expect to complete in coming weeks. Importantly, we expect that the terms of the new revolver will eliminate the secured leverage financial covenant and provide additional headroom under both the fixed charge coverage covenant and the total leverage financial covenant.

We expect that this new covenant package will provide us with significant flexibility to address longer-dated maturities beyond 2027. We are still considering the appropriate size of the new revolver. But in any case, we will purposefully downsize the current revolver commitment of about $1.3 billion to a level more aligned with our current needs.

By doing so, and freeing up the collateral that currently secures our total roughly $1.5 billion credit facility, along with repaying the $200 million term loan, we will create substantial additional secured financing capacity to further refinance our existing debt, including the 2027 notes that I just mentioned.

We continue to evaluate the timing and structure of that refinancing, but we are eager to get it done sooner than later. However, we decide to allocate this $1.5 billion collateral capacity between a revolver and other secured financing alternatives. We expect the result will be that we have no maturities until June 2028 when about $600 million of sterling bonds are due and that expected position does not contemplate use of the cash we have as of September 30.

That cash gives us flexibility to decide which additional longer-term debt to retire and win. To recap what we have previously reported, we received $600 million in sale proceeds in the second quarter. Third quarter, approximately $140 million from Infracore $170 million from the sale of our minority interest in a U.S. joint venture and $370 million from the sale of 2 Idaho facilities.

Both of the U.S. portfolios transacted at sub-7% cap rate. And as a reminder, since 2022, we have sold hospital real estate for which we paid about $5.6 billion for an aggregate sale price of more than $6.8 billion. And we have collateralized another roughly $3.9 billion in assets at underwritten valuations, similarly in excess of our original investments.

Combined, those transactions reflect about a 23% increase in value over our original undepreciated book values. Our bond indentures provide us with flexibility as well. As of September '30, our unencumbered assets to unsecured debt ratio is more than 180%, reflecting substantial headroom in excess of the 150% covenant.

Headroom created by our August financing. We anticipate that further headroom will be created with the completion of step 2, up to 225%. And and it could increase even further with additional transactions that we are considering. That headroom, together with the additional financial covenant headroom and secured financing capacity we expect to create through our revolver extension. As well as further financing optionality provided under our bond indentures will provide us with additional flexibility to continue deleveraging our balance sheet. With that, we'll open up the call for questions. Jesse?

Operator

[Operator Instructions] Your first question comes from the line of Mike Mueller with JPMorgan. Please go ahead.

질의응답

Michael Mueller

I'll ask just 2 HSA questions. I'm sure you're going to get a bunch of priority questions. But -- but when do you expect to now resume rent collections for that portfolio? And at what level compared to the last time you were collecting rent? And then the second question would be -- like what would it take to trigger a real plan B here where you're looking at bringing in completely different operators or just something along those.

Edward Aldag

Mike, I think it's important to note that the operations at these hospitals is very strong. and continues to be strong. Let me just give you some points here. The surgeries, the overall volume is up 14% since September. The surgeries themselves are up 33%. They've recently entered to agreement with Miami's largest HMO that has made these hospitals, the preferred hospital network for their members. That should start increasing the patient volumes even further. I know we always focus on the Miami hospitals, but also in Houston. Sam Houston State University has entered into an agreement to begin their residency program at the St. Joseph Hospital Lea Hospital's residency program has now been accepted and will be started in '27.

Both of those 2 items will increase the CMS reimbursement for HSA, so from an operational standpoint, we feel good about the hospitals. Ovation has been in there for about a month, reviewing the situation at the hospitals reviewing the different procedures.

Since since August, the cash collections at HSA has increased 24%. Those are all significant items. So exactly when they'll start paying rent in, I'm not exactly sure. We certainly haven't projected it at this point. But it's not as if there's an issue with the operations at the hospital it literally has been an issue with the billing and the collections. We have a lot of confidence in Ovation's ability to come in and fix that. And was there a second part of the question?

R. Hamner

When might we do something more drastic.

Edward Aldag

Well, if HSAs operations were declining or continuing to decline. That's certainly an item that we would look at doing. .

Operator

Your next question comes from the line of Varel Granite with Bank of America.

Unknown Analyst

This is Andrew Real on for Farrell. I guess, first, just with asset sale proceeds now in hand, could you just speak in a little more detail to how much room they're creating under the secured debt limit? And then should we expect those proceeds to go towards the remaining 27 maturities?

R. Hamner

Well, in the spirit of everything is fungible, we expect the step 2 financings that I just described will address the remaining [ 2027 ] And that leaves cash from asset sales, as I mentioned, for addressing longer-dated maturities beyond the 27 whether it's sequentially just to bring down the 28 sort to spread it across the maturities, we have those -- we have that optionality. But we haven't made any specific determination at this point. .

Unknown Analyst

Okay. And then where does the working capital balance to HSA stand today .

R. Hamner

Our loan to HSA. You said.

Unknown Analyst

Correct .

R. Hamner

About $150 million. .

Operator

Your next question comes from the line of Michael Carroll with RBC Capital Markets.

Unknown Analyst

I guess, Ed or Steve, can you provide some additional color on the priority lease restructuring? Like what did MPT receive in return for the rent cut? I know you mentioned something that MPT can share on the upside when the recovery happens. Is that like some form of percentage rent. And then you said there was an ability to extend the lease termeture option. When does the lease expire now and you can extend it out 10 years from that point?

Edward Aldag

Yes. So Mike, let me -- I'll answer your questions, but let me point out that we have a great deal of confidence in Priority's ability to operate. This truly is in a situation where there's a lack of demand or inability to operate. We believe that priority is absolutely the best operator for these facilities. This is entirely a situation where the U.K. government and obviously, where we're concerned, particularly the NHS as budget constraints and has limited the number of NHS patients in April health facilities. Probably the most important thing that we received out of this is greatly enhancing our financial credit with the parent company priority.

R. Hamner

That's the main thing, Mike, is, as I just mentioned, we have a much improved credit perimeter with Priory and actually its ownership parent. Our ability now is to extend the lease to 2055. That's totally within our discretion. And yes as revenue recovers, whether from NHS or elsewhere, we have the opportunity to recover the foregone rent I think Kevin mentioned starting at 11 million pounds that escalates.

But as revenue recovers, the rent would also recover. And I would point out that in recent weeks, if not months, -- we think we did this at the bottom because revenue is already increasing. We're already seeing improving operations in revenue at Priory.

Unknown Analyst

And then switching over to NOR and HSA. It looks like in the supplemental on the development tab that the budget for the NOR development and some of the HSA developments increased pretty noticeably. specifically at NOR. Can you kind of talk about what drove those increases? I mean did new projects get added to that? Or did the scope of the existing projects just get bigger?

Edward Aldag

Remember that on or the vast majority of that is for a new ET at the largest hospital in that portfolio. And that actually started under the previous owners prospect. Obviously, there's also the continued seismic work that's going on there, but the vast majority of it is the -- that's an important project. It was an important project on a prospect. It got sidelined during the bankruptcy, and it's back in full speed.

Unknown Executive

The -- all that to with that HSA is primarily elevators, boil, chillers, roofs, basic type of situation. The biggest project is the project that we announced a while back, which is the replacement of a parking garage at Haile.

Unknown Analyst

And then just if I can sneak 1 last 1 in there. I guess, Steve, can you talk about I guess, how MPT plans on raising additional capital? I know you talked a little bit about some -- the Phase 2 of the debt refinancing. I mean are there more asset sales on TAP? And at what point do you start thinking about the dividend just given where earnings have been trending with the priority in the HSA situations.

R. Hamner

So as we've discussed below these many quarters now, we continue to have a lot of flexibility, Mike. You mentioned asset sales. There's nothing meaningful pending. We're not in the market for any particular portfolios or assets. I mean there may be a one-off here and there like we've done recently. My point in kind of going through the recent history where we've sold or monetized upwards of $9 billion in assets at significant premiums over our original investment -- what was, in fact, to point out that, that is available.

We continue with the balance sheet restructuring, the extension of maturities and modest reduction of debt to give us longer runway to continue improving operations, including with the HSA situation. So we have options, and we have the luxury of some time before we have to or would consider more drastic alternatives.

Operator

This concludes today's Q&A. I will now turn the call back over to Ed Aldag, CEO, for closing remarks.

Edward Aldag

Thank you, Jesse. And if anybody has any follow-up questions, please don't hesitate to reach out to Charles, and we'll get back with you. So thank you very much. .

Operator

This concludes today's call. Thank you for attending. You may now disconnect.

이 문서에는 사람이 검토한 AI 생성 콘텐츠 또는 AI 번역 콘텐츠가 포함될 수 있습니다. 이는 참고용 및 전반적인 정보를 제공용으로만 제공되며 투자 조언에 해당하지 않습니다.

면책 조항: 이 웹사이트에서 제공되는 정보는 교육적이고 정보 제공을 위한 목적으로만 사용되며, 금융 또는 투자 조언으로 간주되어서는 안 됩니다.

코멘트 (0)

$ 버튼을 클릭하고, 종목 코드를 입력한 후 주식, ETF 또는 기타 티커를 연결합니다.

0/500
코멘트 가이드라인
로딩 중...

추천 기사

tradingkey.logo
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유